Interaksi Aztreonam
Aztreonam (Azactam, Cayston), golongan antibiotik, memiliki 46 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 0 mayor, 46 moderat, 0 minor, dan 0 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.
Interaksi dari label
Interaksi moderat (46)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (label Aztreonam, Peringatan dan perhatian)
Periksa Aztreonam terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.
Buka di pemeriksaBukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.